![]() |
市場調查報告書
商品編碼
1403380
2030 年點膠自動化機械市場預測:按產品、最終用戶和地區進行全球分析Pharmacy Automation Machine Market Forecasts to 2030 - Global Analysis By Product, End User and By Geography |
根據 Stratistics MRC 的數據,2023 年全球藥局自動化市場規模為 36.1 億美元,預計預測期內複合年成長率為 9.5%,到 2030 年將達到 68.2 億美元。
「藥局自動化」一詞描述如何在製藥企業中使用自動化系統和技術來簡化和增強與藥品管理和分銷相關的許多領域。處方箋匹配、電腦化庫存管理、機器人配藥設備和自動化包裝解決方案都包含在這些系統中。
根據聯合國《世界人口高齡化報告(2019)》,東亞和東南亞的老年人口將增加一倍,65歲及以上人口從2019年的2.606億增加到2050年的550萬。這一數字將增至近7250萬人。
隨著醫療保健產業採用電子健康記錄(EHR) 和數位處方箋系統,將藥房與數位平台整合至關重要。藥房自動化促進了這一發展,藥房自動化提供的技術可以根據電子健康資訊輕鬆監控、驗證和分發處方箋。此外,它還可以幫助藥局跟上不斷變化的醫療保健法規和技術進步,同時提高用藥準確性和病人安全,推動該市場的擴張。
許多藥局的主要財務障礙是購買和安裝自動化設備所需的高成本。較大的藥局可能會猶豫是否引入自動化,因為投資回報時間會更長。此外,自動化的初始成本負擔可能是接受的主要障礙,限制了該技術在製藥業的廣泛使用。
科技提供安全的處方處理、庫存管理和病患監測,以提高病患的便利性和照護品質。藥局自動化技術也使得準確、有效率地向遠方患者分發藥物成為可能。這就是藥房採用和創新新的配藥自動化解決方案的原因。這是由於對遠端藥房和遠端服務的需求不斷增加,從而推動了這一市場的擴張。
不同製造商的多個自動化系統之間潛在的互通性挑戰是一大缺點。由於缺乏標準化而導致溝通和資料交換效率低下,從而導致藥品給藥中的錯誤和低效。此外,缺乏標準化不僅阻礙了擴充性和未來的改進,而且還使藥房工作人員難以接受培訓,因為他們必須學習如何使用許多系統,這將是一個障礙。
藥房自動化市場受到了 COVID-19大流行的負面影響。前所未有的全球健康危機擾亂了整個醫療保健產業的供應鏈、計劃延遲和財政資源緊張。許多藥局面臨採用或升級自動化技術的挑戰,以解決病患數量增加、資源限制和供不應求緊迫問題。此外,關門和社交距離政策也減少了患者去藥局的次數,影響了自動化解決方案的市場。
由於桌面尺寸較小的設備可以準確、快速地對錠劑和膠囊中的藥物進行計數,因此自動桌面計數器部分預計將佔據最大佔有率。自動桌上型計數器通常使用最尖端科技來快速且準確地計算藥物單位,從而提高病患安全和業務效率。此外,這些技術的範例包括光學感測器、機器人和軟體演算法。透過解決處方箋管理的關鍵要素,我們支持整個配藥自動化業務的擴展並推動該領域的成長。
由於專為醫院藥房設計的先進自動化系統和技術,預計醫院藥房行業在預測期內將出現最高的複合年成長率。醫院藥局正在使用自動化進行庫存管理、藥品包裝和藥品配發,以簡化流程並降低出錯風險。準確、及時的給藥對於大型醫療機構也至關重要,這些系統需要改善患者照護、降低成本並滿足日益成長的醫療服務需求,是市場擴張的驅動力。
亞太地區在估計期間佔據了最大的市場佔有率,因為向藥房提供財政援助和其他獎勵的各種政府舉措對於推進藥房自動化非常重要。印度、日本和中國等國家正在重視數位醫療活動,透過將藥房自動化整合到更大的醫療保健生態系統中來促進創新和技術改進。此外,醫療保健提供者擴大投資於尖端自動化技術,以減少用藥錯誤、改善庫存管理並提高患者安全,從而推動該地區的成長。Masu。
預計歐洲在預測期內將經歷最高的複合年成長率。這是因為遠距醫療和遠距處方服務已成為接受藥物治療的患者的普及。在歐洲,資料分析和人工智慧正在結合,以改善藥品庫存管理並準確預測需求。該地區是許多主要企業的所在地,包括 McKesson Corporation、Becton、Dickinson and Company、Capsa Healthcare 和 Cerner Corporation,為醫療保健提供者提供自動化解決方案,最大限度地減少錯誤並確保合規性。我們鼓勵投資。
According to Stratistics MRC, the Global Pharmacy Automation Market is accounted for $3.61 billion in 2023 and is expected to reach $6.82 billion by 2030 growing at a CAGR of 9.5% during the forecast period. The term "pharmacy automation" describes how automated systems and technology are used in the pharmaceutical business to simplify and enhance a number of areas related to managing and distributing medications. Prescription verification, computerized inventory management, robotic dispensing equipment, and automated packaging solutions are all included in these systems.
According to the UN report on World Population Ageing (2019), Eastern and Southeastern Asia are expected to experience a two-fold increase in the number of geriatric individuals, with the population aged 65 years or over projected to increase from 260.6 million in 2019 to nearly 572.5 million by 2050.
Pharmacy integration with digital platforms is imperative as the healthcare sector embraces electronic health records (EHRs) and digital prescription systems. This development is made easier by pharmacy automation, which provides technologies that can effortlessly monitor, check, and dispenses prescriptions in accordance with electronic health information. In addition, this helps pharmacies stay up-to-date with changing healthcare regulations and technological advancements while also improving drug accuracy and patient safety which is driving this market expansion.
A major financial obstacle for many pharmacies may be the large expenditure needed to acquire and install automation equipment, which includes its high start-up expenses and higher medication filling fees. Slightly larger pharmacies may be discouraged from implementing automation due to the extended ROI time. Further, the initial price burden of automation can be a major barrier to acceptance, restricting the technology's widespread use in the pharmaceutical industry, which thereby hinders this market size.
To improve patient convenience and care quality, technologies provide safe prescription processing, inventory management, and patient monitoring which are done online due to these services, which help pharmacies expand their reach beyond physical locations. Medicines can be accurately and efficiently dispensed to patients who live far away, because in large part to pharmacy automation technologies. Therefore, pharmacies are adopting and innovating new pharmacy automation solutions because of the growing need for telepharmacy and distant services thereby propelling this market expansion.
The possibility of challenges with interoperability between multiple automation systems from different manufacturers is one major disadvantage. Ineffective communication and data interchange caused by this lack of standardization result in mistakes and inefficiencies in the administration of medications. Additionally, inadequate standardization can impede scalability and future improvements, as well as make it more difficult for pharmacy staff to receive training because they must learn to use many systems that hamper this market expansion.
The pharmacy automation market has been negatively impacted by the COVID-19 pandemic. The unprecedented global health crisis disrupted supply chains, delayed projects, and strained financial resources across the healthcare sector. Many pharmacies faced challenges in adopting or upgrading automation technologies as they grappled with immediate concerns such as increased patient loads, resource constraints, and supply shortages. Furthermore, lockdowns and social distancing policies also decreased patient visits to pharmacies, which had an impact on the market for automation solutions.
The automated table-top counters segment is estimated to hold the largest share due to small, desktop-sized devices that count pills or capsules of medication precisely and quickly. They usually use cutting-edge technology to swiftly and precisely count medicine units, improving patient safety and operational effectiveness. Furthermore, examples of these technologies include optical sensors, robotics, and software algorithms. By addressing a critical component of prescription administration, they support the expansion of the pharmacy automation business as a whole, which is boosting this segment's growth.
The hospital pharmacy segment is anticipated to have the highest CAGR during the forecast period due to advanced automated systems and technologies designed for usage in hospital pharmacy settings. Hospital pharmacies use automation to manage inventories, package medications, and compound medications, which streamlines processes and lowers mistake risk. In addition, large medical facilities are in need of these systems because accurate and timely medicine administration is crucial, and in order to improve patient care, cut expenses, and satisfy the growing demand for healthcare services that drives this market expansion.
Asia Pacific commanded the largest market share during the extrapolated period owing to various government initiatives have been significant in advancing pharmacy automation which, provid financial aid and other incentives to pharmacies. Countries such as India, Japan and China contribute in emphasizing digital health activities that promotes innovation and technological improvements by integrating pharmacy automation into larger healthcare ecosystems. In addition, to mitigate medication errors, improve inventory management, and enhance patient safety is pushing healthcare providers to invest in cutting-edge automation technologies thereby driving this region's growth.
Europe is expected to witness highest CAGR over the projection period, owing to telepharmacy and remote prescription services have become more popular for patients to get pharmaceutical care. Data analytics and artificial intelligence have been combined in Europe to improve pharmaceutical inventory management and precisely forecast demand. This region is home to many major key players such as McKesson Corporation, Becton, Dickinson and Company, Capsa Healthcare and Cerner Corporation have encouraged healthcare providers to invest in automation solutions that minimize errors and ensure compliance which are boosting this region's expansion.
Some of the key players in the Pharmacy Automation Market include Accu-Chart Plus Healthcare System Inc., Arxium Inc., Avery Weigh-Tronix , Becton, Dickinson, and Company, PerceptiMed Inc., Capsa Solutions LLC, Swisslog Holdings AG, Cerner Corporation, McKesson Corporation, Omnicell Inc., Yuyama Co. Ltd, Parata Systems LLC, Scriptpro LLC and Rxsafe LLC.
In June 2023, BD (Becton, Dickinson and Company), a leading global medical technology company, announced the worldwide commercial launch of a new automated instrument that prepares samples for clinical diagnostics using flow cytometry, enabling a complete "walkaway" workflow solution designed to improve standardization and reproducibility in cellular diagnostics.
In May 2023, Omnicell, Inc. announced changes to its leadership structure designed to create a more streamlined organization with a continued focus on operational excellence, driving continuous improvements in customer experience and the delivery of Omnicell's long-term commitments.
In April 2023, BD (Becton, Dickinson and Company), a leading global medical technology company, launched a new, easy-to-use advanced ultrasound device with a specialized probe designed to provide clinicians with optimal IV placement.
In October 2022, Omnicell, Inc, a leading provider of medication management and adherence tools for health systems and pharmacies, announced the launch of Specialty Pharmacy Services, a turnkey offering with dedicated services to set up, operate, and optimize a specialty pharmacy program.